Meta-Analysis of the Long-Term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction
- PMID: 31307951
- PMCID: PMC6728809
- DOI: 10.1016/j.esxm.2019.06.006
Meta-Analysis of the Long-Term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction
Abstract
Background: Erectile dysfunction (ED) is highly prevalent in aging men. Tadalafil daily and on-demand are widely used for the treatment of ED.
Aim: We performed a meta-analysis to evaluate the efficacy and safety of tadalafil daily compared with tadalafil on-demand in treating men with ED after at least 24 weeks of long-term treatment.
Methods: Randomized controlled trials of tadalafil daily vs on-demand in treating men with ED were searched using MEDLINE, EMBASE, and the Cochrane Controlled Trials Register. Systematic review was carried out using the Preferred Reporting Items for Systematic Reviews and Meta-analyses. The data was calculated by RevMan version 5.3.0. The references of related articles were also searched.
Outcomes: International Index of Erectile Function-Erectile Function domain, sexual encounter profile question 2 (SEP2), SEP question 3 (SEP3), any treatment-emergent adverse event (AE), discontinuation due to AEs, myalgia, back pain, headache, dyspepsia, and nasopharyngitis.
Results: 4 articles, including 1,035 participants were studied. The analysis found that tadalafil daily had a greater improvement than tadalafil on-demand in terms of International Index of Erectile Function-Erectile Function (mean difference (MD) 1.24; 95% CI 0.03-2.44; P = .04), SEP2 (MD 10.08; 95% CI 9.15-11.01; P < .00001) and SEP3 (MD 8.19; 95% CI 2.09-14.29; P = .009) in treating ED after at least 24 weeks treatment cycle. For safety, tadalafil on-demand had a higher incidence of any treatment-emergent AE (odds ratio 0.73; 95% CI 0.56-0.96; P = .02) compared with tadalafil daily, but for other aspects, including discontinuation due to AEs, myalgia, back pain, headache, dyspepsia, and nasopharyngitis, there were no significant difference between the 2 treatments.
Clinical implications: Tadalafil daily may offer a better effect for ED than on-demand for long-term treatment.
Strengths and limitations: From the perspective of evidence-based medicine, we evaluated the efficacy and safety of tadalafil daily compared with tadalafil on-demand in treating men with ED after a long-term treatment. The quality of these studies included is flawed, primarily in difference in tadalafil doses and severity of the ED.
Conclusion: Tadalafil daily provides a preferable therapeutic effect for ED with a lower incidence of treatment-emergent side effects relative to tadalafil on-demand after at least 24 weeks of long-term treatment. Zhou Z, Chen H, Wu J, et al. Meta-Analysis of the Long-Term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction. J Sex Med 2019;7:282-291.
Keywords: Erectile Dysfunction; Long-Term Therapy; Meta-Analysis; Randomized Controlled Trials; Tadalafil.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Figures







Similar articles
-
A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.J Sex Med. 2011 Sep;8(9):2617-24. doi: 10.1111/j.1743-6109.2011.02353.x. Epub 2011 Jun 27. J Sex Med. 2011. PMID: 21707928 Clinical Trial.
-
Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia and Erectile Dysfunction.Am J Mens Health. 2019 Sep-Oct;13(5):1557988319882597. doi: 10.1177/1557988319882597. Am J Mens Health. 2019. PMID: 31625449 Free PMC article.
-
Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.BJU Int. 2004 Oct;94(6):871-7. doi: 10.1111/j.1464-410X.2004.05049.x. BJU Int. 2004. PMID: 15476525 Clinical Trial.
-
Role of application of tadalafil 5 mg once-daily (≥6 months) in men with erectile dysfunction from six randomized controlled trials.Transl Androl Urol. 2020 Jun;9(3):1405-1414. doi: 10.21037/tau-19-809. Transl Androl Urol. 2020. PMID: 32676425 Free PMC article. Review.
-
Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.Eur Urol. 2014 Feb;65(2):455-64. doi: 10.1016/j.eururo.2013.09.037. Epub 2013 Oct 2. Eur Urol. 2014. PMID: 24119319
Cited by
-
The Effect of Phosphodiesterase-type 5 Inhibitors on Erectile Function: An Overview of Systematic Reviews.Front Pharmacol. 2021 Sep 7;12:735708. doi: 10.3389/fphar.2021.735708. eCollection 2021. Front Pharmacol. 2021. PMID: 34557099 Free PMC article.
-
Assessing Medication Adherence to Tadalafil 5 mg Once Daily in Erectile Dysfunction: A Cross-Sectional Analysis.Pharmacol Res Perspect. 2025 Jun;13(3):e70129. doi: 10.1002/prp2.70129. Pharmacol Res Perspect. 2025. PMID: 40448337 Free PMC article.
-
Response to Letter to the Editor: Meta-Analysis of the Long-term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction.Sex Med. 2020 Jun;8(2):324. doi: 10.1016/j.esxm.2020.01.003. Epub 2020 Feb 7. Sex Med. 2020. PMID: 32044278 Free PMC article. No abstract available.
-
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Tamsulosin Plus Tadalafil Compared With Tamsulosin Alone in Treating Males With Lower Urinary Tract Symptoms Secondary to Benign Prostrate Hyperplasia.Am J Mens Health. 2023 Jan-Feb;17(1):15579883231155096. doi: 10.1177/15579883231155096. Am J Mens Health. 2023. PMID: 36842963 Free PMC article.
-
The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice.World J Mens Health. 2023 Jul;41(3):508-537. doi: 10.5534/wjmh.221027. Epub 2023 Feb 22. World J Mens Health. 2023. PMID: 36876744 Free PMC article. Review.
References
-
- Shamloul R., Ghanem H. Erectile dysfunction. Lancet. 2013;381:153–165. - PubMed
-
- Sánchez-Cruz J.J., Cabrera-León A., Martín-Morales A. Male erectile dysfunction and health-related quality of life. Eur Urol. 2003;44:245–253. - PubMed
-
- Najari B.B., Kashanian J.A. Erectile Dysfunction. JAMA. 2016;316:1838. - PubMed
-
- Hatzimouratidis K., Amar E., Eardley I. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur Urol. 2010;57:804–814. - PubMed